ABSTRACTS European Congress on Obesity (ECO Online 2021) - 28th Congress, 10-13 May, 2021 - Karger ...
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
European Congress on Obesity
(ECO Online 2021)
28th Congress, 10–13 May, 2021
ABSTRACTS
Basel Freiburg Hartford Oxford Bangkok Dubai Kuala Lumpur
• • • • • • •
Melbourne Mexico City Moscow New Delhi Paris Shanghai Tokyo
• • • • • •Disclosure Statement
The abstracts included in this supplement were reviewed and
selected by the EASO Executive Committee and ECO2021 Pro-
gramme Organising Committee. The committees have no conflicts
of interest in connection with the congress and the selection of
abstracts.
S. Karger Disclaimer All rights reserved.
Medical and Scientific Publishers The statements, opinions and data contained in this publica- No part of this publication may be translated into other
tion are solely those of the individual authors and contributors languages, reproduced or utilized in any form or by any means,
Basel Freiburg Hartford Oxford
• • • •
and not of the publisher and the editor(s). The appearance of electronic or mechanical, including photocopying, recording,
Bangkok Dubai Kuala Lumpur
• • •
advertisements in the journal is not a warranty, endorsement, microcopying, or by any information storage and retrieval
Melbourne Mexico City
• •
or approval of the products or services advertised or of their system, without permission in writing from the publisher or,
Moscow New Delhi Paris
• • • effectiveness, quality or safety. The publisher and the editor(s) in the case of photocopying, direct payment of a specified fee to
Shanghai Tokyo
• disclaim responsibility for any injury to persons or property the Copyright Clearance Center (see ‘General Information’).
resulting from any ideas, methods, instructions or products
referred to in the content or advertisements. © Copyright 2021 by S. Karger AG,
P.O. Box, CH–4009 Basel (Switzerland)
Drug Dosage e-ISBN 978–3–318–06938–9
The authors and the publisher have exerted every effort to en-
sure that drug selection and dosage set forth in this text are in
accord with current recommendations and practice at the time
of publication. However, in view of ongoing research, changes
in government regulations, and the constant flow of informa-
tion relating to drug therapy and drug reactions, the reader is
urged to check the package insert for each drug for any change
in indications and dosage and for added warnings and precau-
tions. This is particularly important when the recommended
agent is a new and/or infrequently employed drug.
karger@karger.com
www.karger.com/ofaEASO Executive Committee
EASO EC (Trustees)
President: Nathalie Farpour-Lambert, Switzerland
President Elect: Jason Halford, UK
Secretary: Grace O’Malley, Ireland
Treasurer: Paolo: Sbraccia, Italy
Regional VP North: Jorn Sagen, Norway
Regional VP Middle: Dana Mullerova, Czech Republic
Regional VP South: Volkan Yumuk, Turkey
Ex Officio (Non voting)
COTF Co-Chair: Jennifer Baker, Denmark
COTF Co-Chair: Jens-Christian Holm, Denmark
OMTF Co-Chair: Luca Busetto, Italy
OMTF Co-Chair: Dror Dicker, Israel
PHTF Co-Chair: Janas Harrington, Ireland
PHTF Co-Chair: Daniel Cauchi, Malta
SAB Co-Chair: Gema Frühbeck, Spain
SAB Co-Chair: Gijs Goossens, Netherlands
NWG Co-Chair: Maria Hassapidou, Greece
NWG Co-Chair: Teodora Handjieva-Darlenska, Bulgaria
karger@karger.com © 2021 S. Karger AG, Basel
www.karger.com/ofaVol. 14, Suppl. 1, 2021
Contents
PLENARY LECTURES
Monday, 10 May 2021
1 PL1 – Central Regulation of Metabolism
1 PL2 – New Insights into Adipose Tissue
Tuesday, 11 May 2021
1 PL3 – Obesity and Pregnancy
1 PL4 – COVID19: Impacts on Child and Adolescent Health and Lifestyle
Wednesday, 12 May 2021
1 PL5 – Reassessing Prevention: From Children to the Elderly
2 PL6 – Sustainability, Food Systems and Climate Change
Thursday, 13 May 2021
2 PL7 – Lipodistrophy / Sarcopenic Obesity
2 PL8 – Predimed Studies
TOPIC SESSION
Monday, 11 May 2021
3 TS01 – Central Regulation of Metabolism
4 TS02 – Obesity & Cancer
5 TS03 – Inter-organ Communication / Integrative Physiology
6 TS04 – Adipose Tissue Biology
Tuesday, 11 May 2021
8 TS05 – Physical Fitness and Physical Activity
9 TS06 – Mental Health
11 TS07 – Successful Interventions for Obesity Prevention and Treatment in Children
and Adolescents
11 TS08 – Child Nutrition and Health
Wednesday, 12 May 2021
12 TS09 – Obesity and COVID19: Underlying Mechanisms and Clinical Implications
12 TS10 – Apps: What Are They Good for?
12 TS11 – Modelling Obesity Scenarios at Regional, National and European Levels
12 TS12 – Mental Health and Obesity Stigma
Thursday, 13 May 2021
13 TS13 – Drug Treatment of Obesity in Adults
13 TS14 – Personalized Treatment of Obesity
14 TS15 – Weight-reduced Markers, to Prevent Weight Regain
15 TS16 – Special Dieting
IV ContentsACCEPTED SYMPOSIUM
Monday, 10 May 2021
15 AS1 – Different Approaches Towards Personalised Nutrition–Status Quo and Future
Directions
Tuesday, 11 May 2021
16 AS2 – Beyond Body Mass Index: Positioning Body Composition In The Nutrition
Assessment Menu
Wednesday, 12 May 2021
16 AS3 – The EU PROTEIN Project
16 AS4 – The impact of COVID-19 Measures on Lifestyle and Weight: Towards Positive
Solutions
16 AS5 – COllaBoration in Health Economic Modelling of OverWEight and oBesity:
An invitation to the Cobweb Network
Thursday, 13 May 2021
17 AS6 – Understanding Sarcopenic Obesity: The Ignored Phenotype?
EASO OMTF SESSION – SLEEP, HEALTH AND OBESITY
Thursday, 13 May 2021
17 TF1 – Sleep, Health and Obesity
ABSTRACT DISCUSSION SESSION
Monday, 10 May 2021
19 AD01 – Integrative Physiology I
23 AD02 – Adipose Tissue Biology
25 AD03 – Integrative Physiology II
Tuesday, 11 May 2021
27 AD04 – Early Life Risk Factors
30 AD05 – Management and Intervention
33 AD06 – Nutrition/Dietary Patterns
35 AD07 – Life Course Approaches
Wednesday, 12 May 2021
37 AD08 – Behaviour Change
40 AD09 – Epidemiology
43 AD10 – Nutrition
45 AD11 – COVID-19
Thursday, 13 May 2021
48 AD12 – Novel Anti-Obesity Medications
54 AD13 – Behavioural and Lifestyle Interventions
58 AD14 – Bariatric Surgery
61 AD15 – Obesity Complications – COVID-19
Contents VE-POSTER PRESENTATION
66 EP1 – Basic Science
80 EP2 – Childhood and Adolescent Obesity
93 EP3 – Behavioural and Public Health
107 EP4 – Management and Intervention
147 Author Index
155 Late Breaking Abstracts
195 Author Index Late Breaking Abstracts
VI ContentsYou can also read
